2025-12-10 21:51 |
The post Evening digest: Fed rate cut loading, China’s Nvidia chip push, Bitcoin rebound drive market mood appeared first on Invezz
origin »Bitcoin price in Telegram @btc_price_every_hour
|
China is tightening access to Nvidia’s most advanced AI chips even as the US approves exports. Microsoft is making a record $17. 5B bet on India’s AI future, and Australia has imposed an unprecedented nationwide social media ban for teens.
2025-12-10 21:52 | |
|
|
Asian markets retreated on Thursday as investors rotated out of technology stocks amid mounting concerns over the escalating cost of artificial intelligence investment. At the same time, precious metals markets were rocked by another sharp decline in silver prices, while geopolitical and macroeconomic developments, including renewed US-China engagement and continued weakness in bitcoin, added to […]
Markets are ending the day on edge as sharp moves ripple across stocks, commodities, and crypto. AMD slumped despite an earnings beat, underscoring how unforgiving investors have become around AI expectations.
A fresh wave of macro stress and technical breakdowns pushed Bitcoin price deep into correction territory as traders remained defensive.
Assets under management in US spot Bitcoin exchange-traded funds slipped below $100 billion on Tuesday, following renewed investor withdrawals and a sharp downturn across the broader cryptocurrency market.
OG enters a growing but contentious space as Crypto.com separates its event-driven trading from its core crypto business.
Polymarket is stepping away from screens and apps and into the physical world. The crypto-based prediction market platform is opening a free grocery store in New York City, pairing the initiative with a major donation aimed at tackling food insecurity.
Tonight’s digest tracks a trillion-dollar retail coronation, a fragile geopolitical tariff truce, a pharma darling losing its halo, and crypto’s brutal reminder that liquidity rules all. Walmart’s transformation is real, India’s leverage play is bold but murky, Novo Nordisk’s stumble exposes execution risk, and Bitcoin’s slide confirms it’s trading like a high-beta asset, not digital […]